Skip to main content
Clinical Trials/NCT05604989
NCT05604989
Completed
Phase 3

Associations Between the Oral and Intestinal Microbiome and Neovascular Age-related Macular Degeneration and the Investigation on the Effect of Oral Probiotics as a Treatment - A Pilot Study

Seoul National University Bundang Hospital1 site in 1 country45 target enrollmentJanuary 1, 2023

Overview

Phase
Phase 3
Intervention
Probiotic Combination Cap/Tab
Conditions
Neovascular Age-related Macular Degeneration
Sponsor
Seoul National University Bundang Hospital
Enrollment
45
Locations
1
Primary Endpoint
Oral microbiome changes after oral probiotics supplement in neovascular AMD patients
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

A pilot study for Associations between the oral and intestinal microbiome and neovascular age-related macular degeneration and the investigation on the effect of oral probiotics as a treatment

The investigators recruit the neovascular AMD patients and control patients.

  1. 15 neovascular AMD patients with anti-VEGF treatment and oral probiotics supplement
  2. 15 neovascular AMD patients with anti-VEGF treatment and no oral probiotics supplement
  3. 15 control patients and no oral probiotics supplement

The investigators will collect stool, blood, and saliva sample at the baseline and 6 months, and analyze the oral and intestinal microbiome changes.

Registry
clinicaltrials.gov
Start Date
January 1, 2023
End Date
November 30, 2024
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

KWANGSIC JOO

Director, Deparment of Ophthalmology, Principal Investigator, Clinical Professor

Seoul National University Bundang Hospital

Eligibility Criteria

Inclusion Criteria

  • Normal BMI patients
  • Diagnosed as neovascular AMD (experimental \& sham group)
  • Normal patients (control group)

Exclusion Criteria

  • Obese (BMI \> 30)
  • Past surgical history involving intestinal diseases
  • Previous oral antibiotic treatment before 1 week at the baseline enroll
  • Previous oral probiotics supplement
  • Previous ophthalmic retinal diseases except neovascular AMD

Arms & Interventions

Neovascular AMD patients with anti-VEGF treatment, oral probiotics supplement

Neovascular AMD patients will be allocated. Regular intravitreal anti-VEGF injection treatment will be done. At the baseline and 6 months, the investigators will collect stool, saliva, and blood samples for microbiome analysis. Oral probiotics (The Perfect Probiotics®) supplement will be given to the participants for 6 months.

Intervention: Probiotic Combination Cap/Tab

Neovascular AMD patients with anti-VEGF treatment, oral probiotics supplement

Neovascular AMD patients will be allocated. Regular intravitreal anti-VEGF injection treatment will be done. At the baseline and 6 months, the investigators will collect stool, saliva, and blood samples for microbiome analysis. Oral probiotics (The Perfect Probiotics®) supplement will be given to the participants for 6 months.

Intervention: intravitreal Anti-VEGF injection

neovascular AMD patients with anti-VEGF treatment, no oral probiotics supplement

Neovascular AMD patients will be allocated. Regular intravitreal anti-VEGF injection treatment will be done. At the baseline and 6 months, the investigators will collect stool, saliva, and blood samples for microbiome analysis. No Oral probiotics (The Perfect Probiotics®) supplement in this group.

Intervention: intravitreal Anti-VEGF injection

Outcomes

Primary Outcomes

Oral microbiome changes after oral probiotics supplement in neovascular AMD patients

Time Frame: 6 months after enrollment

The investigators will analyze the oral microbiome changes (baseline and 6 months after taking oral probiotics) in experimental, sham, and control groups. Microbiome relative abundance changes in percentage (%) will be statistically analyzed between baseline and 6 months.

Intestinal microbiome changes after oral probiotics supplement in neovascular AMD patients

Time Frame: 6 months after enrollment

The investigators will analyze the intestinal microbiome changes (baseline and 6 months after taking oral probiotics) in experimental, sham, and control groups. Microbiome relative abundance changes in percentage (%) will be statistically analyzed between baseline and 6 months.

Secondary Outcomes

  • Visual acuity changes after oral probiotics supplement(6 months after enrollment)

Study Sites (1)

Loading locations...

Similar Trials